Literature DB >> 24633470

Fatigue in breast cancer patients: psychometric evaluation of the fatigue questionnaire EORTC QLQ-FA13.

Kerstin Fuhrmann1, Anja Mehnert2, Kristina Geue1, Andreas Hinz3.   

Abstract

BACKGROUND: Fatigue is a frequent symptom in breast cancer patients and breast cancer survivors. The aims of this study were to test a newly developed fatigue questionnaire (EORTC QLQ-FA13) and to detect prognostic factors of fatigue.
METHODS: A total of 308 breast cancer patients (response rate: 91 %) were tested with the fatigue questionnaire EORTC QLQ-FA13 and the fatigue scale of the EORTC QLQ-C30. In addition, several other questionnaires were also adopted.
RESULTS: The youngest age group of breast cancer patients was most strongly affected by fatigue. The psychometric analysis of the EORTC QLQ-FA13 supported a three-dimensional structure (physical, emotional, and cognitive fatigue). The reliability (Cronbach's alpha = 0.94) was very good. Clinical factors such as time since diagnosis and received therapy did not significantly predict the level of fatigue.
CONCLUSION: Fatigue remains a severe problem in breast cancer patients, especially in younger women. Researchers or clinicians who want to measure fatigue have the choice between the short 3-item fatigue scale of the EORTC QLQ-C30, stressing the physical aspect of fatigue, and the long 13-item EORTC QLQ-FA13 scale with slightly better psychometric properties, including cognitive and emotional aspects of fatigue.

Entities:  

Keywords:  Cancer survivors; Fatigue; Psycho-oncology; Quality of life

Mesh:

Year:  2014        PMID: 24633470     DOI: 10.1007/s12282-014-0527-1

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  3 in total

1.  Fatigue in the general population: German normative values of the EORTC QLQ-FA12.

Authors:  Andreas Hinz; Joachim Weis; Elmar Brähler; Anja Mehnert
Journal:  Qual Life Res       Date:  2018-06-16       Impact factor: 4.147

2.  Temporal stability of quality of life assessments in cancer patients.

Authors:  Andreas Hinz; Thomas Schulte; Jörg Rassler; Markus Zenger; Kristina Geue
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

3.  Comparative responsiveness and minimally important difference of Fatigue Symptom Inventory (FSI) scales and the FSI-3 in trials with cancer survivors.

Authors:  Catherine E Mosher; Ekin Secinti; Shelley A Johns; Kurt Kroenke; Laura Q Rogers
Journal:  J Patient Rep Outcomes       Date:  2022-07-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.